DNAJC9

DNAJC9 is a dual-function heat shock co-chaperone and histone chaperone that integrates ATP-dependent protein folding into the histone H3-H4 supply chain to support nucleosome assembly (PMID:33857403). It binds H3-H4 substrates and recruits HSP70-type chaperones through its J domain to fold histones, operating upstream in the histone supply chain during replication- and transcription-coupled nucleosome assembly and resolving spurious histone interactions, with a structurally defined co-chaperone complex involving MCM2 (PMID:33857403). DNAJC9 engages histone H3 via helix α3, a binding mode that precludes simultaneous Asf1 binding, so that the two compete for H3-H4 dimers; in this configuration DNAJC9 also drives degradation of superfluous or dysfunctional histones and confers resistance to replication stress and toxic histone mutants (PMID:39878217). Maintaining H3-H4 supply-chain fidelity restricts CENP-A mislocalization: loss of DNAJC9 promotes ectopic genome-wide CENP-A deposition and chromosomal instability through MCM2, which acts as the downstream driver of this aberrant deposition (PMID:38600242). In genome maintenance, DNAJC9 supplies new H3-H4 to the CAF-1 and HIRA deposition pathways and stimulates recovery of old histones during chromatin repair after UV damage, cooperating with MCM2 to coordinate old and new histone dynamics (PMID:41605964). Through its control over histone deposition, DNAJC9 also promotes active transcription by modulating H3.3 and H3K27ac at regulatory elements, including sustaining p300–H3 contact to drive GLI1 enhancer activity in cervical cancer cells (PMID:42185231) and activating HBV cccDNA transcription (PMID:40407066).

1. 2001 Medium

   Before any functional role was known, the gene was defined as a DnaJ-family member by its molecular architecture, establishing it as a J-domain co-chaperone lacking the G/F and zinc-finger regions.

   Evidence cDNA cloning, immunoblot, and in situ hybridization of the rat ortholog JDD1 in embryonic brain and other tissues

   PMID:11444854

   Open questions at the time

   • No substrate or biochemical activity identified
   • Function inferred only from domain composition, not assayed
   • Localization is at mRNA level in rat, not protein-level subcellular assignment
2. 2021 High

   The central question of what DNAJC9 chaperones was answered by showing it is a histone chaperone that recruits HSP70 via its J domain to fold H3-H4, defining it as the link between ATP-dependent chaperones and the histone supply chain.

   Evidence Cryo-EM/structural determination of the DNAJC9–H3-H4–MCM2 complex with Co-IP, mass spectrometry, and functional proteomics, corroborated by an accompanying commentary

   PMID:33857403 PMID:34143966

   Open questions at the time

   • Did not establish how DNAJC9 hands off histones to downstream deposition machinery
   • Physiological consequences of disrupting the J-domain/HSP70 interaction not tested in vivo
   • Relationship to Asf1 and other handoff chaperones not resolved
3. 2024 High

   The genome-stability consequence of DNAJC9 loss was placed mechanistically by showing that disrupting the H3-H4 supply chain causes MCM2-dependent ectopic CENP-A deposition and chromosomal instability.

   Evidence Genome-wide RNAi screen, global interactome analysis, genetic epistasis (DNAJC9/MCM2 double depletion), and live-cell imaging in human cells

   PMID:38600242

   Open questions at the time

   • Mechanism by which MCM2 redirects CENP-A to ectopic sites not fully defined
   • Whether CENP-A mislocalization is direct or secondary to general supply-chain failure unclear
   • Does not distinguish replication- versus transcription-coupled contributions
4. 2025 High

   The structural and functional relationship to Asf1 was resolved by showing DNAJC9 binds H3 helix α3 in a manner mutually exclusive with Asf1 and promotes degradation of excess or dysfunctional histones.

   Evidence AlphaFold-based structural prediction validated by in vitro competition binding, H3-α3 point mutations, and genetic epistasis under replication stress in fission yeast

   PMID:39878217

   Open questions at the time

   • The degradation machinery DNAJC9 routes histones to is not identified
   • Conservation of the Asf1 competition in human cells not directly tested here
   • How the balance between folding and degradation is regulated is unknown
5. 2025 Medium

   DNAJC9 was extended beyond cellular chromatin into viral chromatin, showing it binds HBV cccDNA independently of histone or sequence and activates its transcription by raising H3.3, H3K4me3, and H3K27ac density.

   Evidence DNA pull-down, cccDNA ChIP, Co-IP, dual luciferase reporter, and immunofluorescence in HBV infection/replication cell models

   PMID:40407066

   Open questions at the time

   • Mechanism of histone-independent cccDNA binding not structurally defined
   • Whether this reflects a normal cellular function co-opted by HBV is unclear
   • Single-lab study without independent replication
6. 2026 Medium

   DNAJC9's role in chromatin repair was defined by showing it supplies new H3-H4 to CAF-1/HIRA and aids recovery of old histones during UV damage repair, cooperating with MCM2.

   Evidence Quantitative time-resolved proteomic profiling of chromatin dynamics during UV damage repair in human cells

   PMID:41605964

   Open questions at the time

   • Direct physical contacts with CAF-1 and HIRA not biochemically dissected here
   • Distinction between new-histone supply and old-histone recovery roles not mechanistically separated
   • Single-lab proteomic study
7. 2026 Medium

   A transcriptional/oncogenic output was established by showing DNAJC9 sustains H3K27ac at the GLI1 enhancer via p300–H3 contact to drive proliferation, demonstrating chromatin-supply control feeds into gene regulation.

   Evidence siRNA knockdown, GLI1 rescue, H3K27ac ChIP, p300–H3 Co-IP, and proliferation/tumor assays in cervical cancer cells

   PMID:42185231

   Open questions at the time

   • Whether the GLI1 effect is direct or downstream of global H3.3/H3K27ac changes unclear
   • Generalizability beyond cervical cancer not tested
   • Mechanism by which DNAJC9 facilitates p300–H3 interaction not defined

• How DNAJC9 mechanistically partitions H3-H4 between folding, deposition (CAF-1/HIRA), degradation, and competition with Asf1, and how this is regulated across replication, transcription, and damage contexts, remains unresolved.
• No unified model of how histone fate is selected
• Regulatory inputs controlling DNAJC9 activity unknown
• Human counterpart of yeast Asf1 competition not directly demonstrated in vivo